natgillin/translations-raw huggingface dataset:
The dosing pump must only be used with the Memantine Merz solution in the bottle provided, not for other substances or containers. 
Pumpica za doziranje smije se koristiti samo za Memantine Merz otopinu u predviđenoj boci, a ne za druge tvari ili spremnike.
Component of a multipack, can't be sold separately. 
Sastavni dio višestrukog pakiranja ne može se prodavati odvojeno.
Only limited experience with overdose is available from clinical studies and post-marketing experience. 
Iz kliničkih ispitivanja i postmarketinškog iskustva dostupno je samo ograničeno iskustvo u vezi s predoziranjem.
What Memantine Merz looks like and contents of the pack 
Kako Memantine Merz izgleda i sadržaj pakiranja
Each tablet contains 5/10/15/20 mg of memantine hydrochloride equivalent to 4.15/8.31/12.46/16.62 mg memantine. 
Jedna tableta sadržava 5/10/15/20 mg memantinklorida, što odgovara 4,15/8,31/12,46/16,62 mg memantina.
Mon → Tue → Wed → Thu → Fri → Sat → Sun 
Pon → Uto → Sri → Čet → Pet → Sub →Ned
At the beginning of treatment you will start by using Memantine Merz 5 mg film-coated tablets once a day. 
Liječenje ćete započeti korištenjem Memantine Merz filmom obloženih tableta od 5 mg jedanput na dan.
Studies in volunteers have demonstrated linear pharmacokinetics in the dose range of 10 to 40 mg. Pharmacokinetic/pharmacodynamic relationship 
Linearnost Ispitivanja na dobrovoljcima pokazala su linearnu farmakokinetiku u rasponu doza od 10 do 40 mg.
When daily doses of 5 to 30 mg were administered, a mean cerebrospinal fluid (CSF)/serum ratio of 0.52 was calculated. 
Pri primjeni dnevnih doza od 5 do 30 mg izračunata je aritmetička sredina omjera cerebrospinalni likvor (CSL)/serum od 0,52.
CARTON AND LABEL FOR 50 ml BOTTLE AS INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX) 
KUTIJA I NAJEPNICA ZA BOCU OD 50 ml KAO SREDNJE PAKIRANJE / DIO VIŠESTRUKOG PAKIRANJA (BEZ PLAVOG OKVIRA)
For the intended use the dosing pump is only screwed on once when starting the use, and should never be unscrewed. 
Za namijenjenu uporabu pumpicu za doziranje treba pričvrstiti zavrtanjem samo jednom na početku uporabe te je ne bi više trebalo odvrtati.
How to store Memantine Merz Content of the pack and other information 
Kako čuvati Memantine Merz Sadržaj pakiranja i druge informacije
In man, about 80% of the circulating memantine-related material is present as the parent compound. 
Kod ljudi je oko 80% memantina u cirkulaciji prisutno u nepromijenjenom obliku.
In another monotherapy study in mild to moderate Alzheimer's disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised. 
U drugom monoterapijskom ispitivanju blage do umjerene Alzheimerove bolesti randomizirano je ukupno 470 bolesnika (početne vrijednosti ukupnog MMSE od 11-23).
OTHER SPECIAL WARNING(S), IF NECESSARY 
DRUGO (A) POSEBNO (A) UPOZORENJE (A) AKO JE POTREBNO
The solution also contains potassium sorbate and sorbitol (E 420). 
Otopina također sadrži kalijev sorbat i sorbitol (E420).
H. Lundbeck AS Tlf: +47 91 300 800 
Lundbeck AS Tlf: +47 91 300 800
Preparing the dosing pump: 
Priprema pumpice za doziranje:
The other ingredients are: potassium sorbate, sorbitol (E 420) and purified water. 
Drugi sastojci su: kalijev sorbat, sorbitol E420 i pročišćena voda.
The bottle with the mounted pump must be kept and transported in an upright position only. 
Boca s namještenom pumpicom mora se čuvati i prenositi samo u uspravnom položaju.
Alkalisation of urine may result from drastic changes in diet, e.g. from a carnivore to a vegetarian diet, or from the massive ingestion of alkalising gastric buffers. 
Alkalizaciju urina može izazvati drastična promjena načina prehrane, npr. prelazak s mesne na vegetarijansku prehranu ili uzimanje izrazito velike količine alkalizirajućih želučanih pufera.
Memantine Merz should be administered orally once a day. 
Memantine Merz treba primjenjivati na usta jedanput na dan.
The dosing pump head can then be released and is ready for the next pump actuation. 
Nakon toga pumpicu za doziranje možete otpustiti te je spremna za sljedeći potisak.
In the overdose cases below 140 mg or unknown dose the patients revealed symptoms from central nervous system (confusion, drowsiness, somnolence, vertigo, agitation, aggression, hallucination and gait disturbance) and/or gastrointestinal origin (vomiting and diarrhoea). 
U slučajevima predoziranja s dozom manjom od 140 mg ili nepoznatom dozom, bolesnici su opisivali simptome središnjeg živčanog sustava (konfuziju, omamljenost, somnolenciju, vrtoglavicu, agitaciju, agresiju, halucinacije i poremećaj hoda) i/ili gastrointestinalne simptome (povraćanje i proljev).
three pump actuations week 4 and beyond four pump actuations 
4. tjedan i nadalje četiri potiska pumpice
Memantine Merz oral solution is presented as a clear, colourless to light yellowish solution. 
Memantine Merz oralna otopina je bistra, bezbojna do svijetlo žućkasta otopina.
If you suffer from renal impairment (kidney problems), your doctor should closely monitor your kidney function and if necessary adapt the memantine doses accordingly. 
Ako imate oštećenje bubrežne funkcije (probleme s bubrezima), liječnik treba pažljivo funkciju Vaših bubrega i ovisno o njoj prilagoditi dozu memantina, ako je to potrebno.
The most frequently occurring adverse reactions with a higher incidence in the Memantine Merz group than in the placebo group were dizziness (6.3% vs 5.6%, respectively), headache (5.2% vs 3.9%), constipation (4.6% vs 2.6%), somnolence (3.4% vs 2.2%) and hypertension (4.1% vs 2.8%). 
Nuspojave koje su se najčešće pojavljivale s većom incidencijom u skupini bolesnika liječenih Memantine Merz nego u skupini koja je uzimala placebo bile su omaglica (6,3% naspram 5,6%), glavobolja (5,2% naspram 3,9%), konstipacija (4,6% naspram 2,6%), somnolencija (3,4% naspram 2,2%) i hipertenzija (4,1% naspram 2,8%).
If you forget to take Memantine Merz 
Ako ste zaboravili uzeti Memantine Merz
From the fourth week the recommended dose is four pump actuations once daily (1 x 20 mg). 
Od četvrtog tjedna, preporučena doza je četiri potiska pumpice jednom dnevno (1 x 20 mg).
EU/1/12/799/025 28 film-coated tablets EU/1/12/799/026 28 film-coated tablets 
EU/1/12/799/025 28 filmom obloženih tableta EU/1/12/799/026 28 filmom obloženih tableta
Each pack of 28 film-coated tablets for a 4 week treatment schedule contains: 7 x Memantine Merz 5 mg 
Svako pakiranje s 28 filmom obloženih tableta za plan liječenja za 4 tjedna sadrži: 7 x Memantine Merz 5 mg
These compounds act at the same receptor system as memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related) may be more frequent or more pronounced (see also section 4.5). 
Ovi spojevi djeluju na isti sustav receptora kao i memantin pa bi nuspojave (uglavnom povezane sa središnjim živčanim sustavom (SŽS)) mogle biti učestalije ili izraženije (vidjeti također dio 4.5).
Oy H. Lundbeck Ab Puh/Tel: +358 2 276 5000 
Lundbeck Ab Puh/Tel: +358 2 276 5000
Cardiac failure 
Srčani poremećaji
The use of memantine in pregnant women is not recommended. 
Trudnicama se ne preporučuje upotreba memantina.
Therefore, the pump must be prepared (primed) by pushing the dosing pump head down completely five times in succession (fig. 5). 
Stoga se pumpica mora pripremiti potpunim pritiskom vrha pumpice za doziranje prema dolje, pet puta zaredom (sl. 5).
H. Lundbeck AB Tel: +46 4225 4300 
Lundbeck AB Tel: +46 4225 4300
Memantine hydrochloride 
memantinklorid
The bottle should be placed on a flat, horizontal surface, for example a table top, and only use it in a vertical position.. A glass with a little water or a spoon should be hold below the nozzle and the dosing pump head has to be pushed down in a firm but calm and steady manner (not too slowly) right down to the stop (fig. 7, fig. 8). 
Ispod mlaznice treba staviti čašu s malo vode ili žlicu, a vrh pumpice za doziranje treba pritisnuti prema dolje, snažno, ali smireno i mirno (ne presporo) sve do kraja (sl. 7, sl. 8).
Clinical studies 
KLINIČKI PODACI
Phospholipidosis in pulmonary macrophages due to accumulation of memantine in lysosomes was observed in rodents. 
Kod glodavaca je primijećena fosfolipidoza u plućnim makrofazima zbog nakupljanja memantina u lizosomima.
From the fourth week on, the usual dose is 2 tablets once a day (1x 20 mg). 
Od četvrtog tjedna nadalje uobičajena doza je 2 tablete jedanput na dan (1 x 20 mg).
Excipients: The oral solution contains sorbitol. 
Pomoćne tvari: oralna otopina sadržava sorbitol.
Immune systeme disorders 
Poremećaji imunološkog sustava
What Memantine Merz is and what it is used for How does Memantine Merz work 
ŠTO JE MEMANTINE MERZ I ZA ŠTO SE KORISTI Kako djeluje Memantine Merz
SYSTEM ORGAN CLASS 
KLASIFIKACIJA ORGANSKIH SUSTAVA
Hold the dosing pump onto the neck of the bottle and screw it clockwise until it fits firmly (fig. 3). 
Držite pumpicu za doziranje na vratu boce i zavrćite ju u smjeru kazaljke na satu dok nije pričvršćena (sl. 3).
Then the dosing pump needs to be hold onto the neck of the bottle and screwed clockwise until it is firmly attached (fig 3). 
Zatim pumpicu za doziranje treba držati na vratu boce i zavrtati u smjeru kazaljke na satu dok nije pričvršćena (sl. 3).
What Memantine Merz is and what it is used for What you need to know before you take Memantine Merz How to take Memantine Merz Possible side effects 
Što je Memantine Merz i za što se koristi Što morate znati prije nego počnete uzimati Memantine Merz Kako uzimati Memantine Merz
Memantine is a voltage-dependent, moderate-affinity uncompetitive NMDA-receptor antagonist. 
Memantin je nekompetitivni antagonist NMDA-receptora, umjerenog afiniteta i ovisan o voltaži.
Multipack 840 (20 packs of 42) film-coated tablets Multipack 980 (10 packs of 98) film-coated tablets Multipack 1000 (20 packs of 50) film-coated tablets 
Višestruko pakiranje od 840 (20 pakiranja po 42) filmom obloženih tableta Višestruko pakiranje od 980 (10 pakiranja po 98) filmom obloženih tablet Višestruko pakiranje od 1000 (20 pakiranja po 50) filmom obloženih tableta
PARTICULARS TO APPEAR ON THE OUTER PACKAGING INNER CARTON FOR BLISTER PACK; front and backside 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU UNUTARNJA KUTIJA ZA BLISTER; prednja i stražnja srana
One treatment initiation pack contains 28 tablets in 4 blisters with 7 tablets of Memantine Merz 5 mg, 7 tablets of Memantine Merz 10 mg, 7 tablets of Memantine Merz 15 mg and 7 tablets of Memantine Merz 20 mg. 
Jedno pakovanje za početak liječenja sadržava 28 tableta u 4 blistera sa 7 Memantine Merz tableta od 5 mg, 7 Memantine Merz tableta od 10 mg, 7 Memantine Merz tableta od 15 mg i 7 Memantine Merz tableta od 20 mg.
Common (may affect up to 1 in 10 users): 
Često (mogu se javiti u do 1 na 10 osoba):
Memantine Merz belongs to a group of medicines called NMDA-receptor antagonists. 
Memantine Merz spada u skupinu lijekova poznatih kao antagonisti NMDA
This is increased to one tablet once a day (1x 10 mg) in the second week and to 1 and a half tablet once a day in the third week. 
Ova doza se povećava na jednu tabletu jedanput na dan (1 x 10 mg) u drugom tjednu te na jednu i pol tabletu jednom dnevno u trećem tjednu.
Film-coated tablet. 
Filmom obložena tablete.
A pivotal monotherapy study of memantine in the treatment of mild to moderate Alzheimer's disease (MMSE total scores at baseline of 10 to 22) included 403 patients. 
U pivotalno ispitivanje monoterapije memantinom u liječenju blage do umjerene Alzheimerove bolesti (početne vrijednosti ukupnog MMSE od 10 do 22) bila su uključena 403 bolesnika.
Measure the dose onto a spoon or into a glass of water, using the pump. 
Pomoću pumpice izmjerite dozu u žlicu ili u čašu vode.
The active substance is memantine hydrochloride. 
Djelatna tvar je memantinklorid.
These events have been reported in patients treated with Memantine Merz. 
Ovi su događaji prijavljivani kod bolesnika liječenih Memantine Merzom.
Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70 to 150 ng/ml (0.5 - 1 µmol) with large interindividual variations. 
Dnevne doze od 20 mg dovode do plazmatskih koncentracija memantina u stanju dinamičke ravnoteže u rasponu od 70 do 150 ng/ml (0,5-1 µmol) s velikim interindividualnim razlikama.
The solution may only be dispensed in the unlocked position. 
Otopina se može raspršiti samo u otključanom položaju.
Pack sizes of 14, 28, 30, 42, 50, 56, 98, 100, 112, and multipacks containing 840 (20 x 42), 980 (10 x 98) or 1000 (20 x 50) tablets are presented. 
Postoje veličine pakiranja od 14, 28, 30, 42, 50, 56, 98, 100, 112, višestruko pakiranje od 840 (20 x 42), 980 (10 x 98) ili 1000 (20 x 50) tableta.
No cytochrome P 450 catalysed metabolism has been detected in vitro. 
In vitro nije otkriven metabolizam kataliziran citokromom P 450.
Memantine Merz should be administered once a day and should be taken at the same time every day. 
Merz se mora primjenjivati jednom dnevno i potrebno ju je uzimati svaki dan u isto vrijeme.
The dosing pump is only screwed on once when starting the use, and should never be unscrewed. 
Pumpicu za doziranje treba pričvrstiti zavrtanjem jednom na početku uporabe te je više ne bi trebalo odvrtati.
The other ingredients for Memantine Merz 5/10/15 and 20 mg film-coated tablets are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171) and additional for Memantine Merz 10 mg film-coated tablets is iron oxide yellow (E172) and for Memantine Merz 15 mg and Memantine Merz 20 mg film-coated tablets are iron oxide yellow and red (E 172), all in the tablet coating. 
Drugi sastojci Memantine Merz 5/ 10/ 15 i 20 mg filmom obloženih tableta su mikrokristalična celuloza, umrežena karmelozanatrij, koloidni bezvodni silicijev dioksid i magnezijev stearat sve u jezgri tablete; te hipromeloza, makrogol 400, titanijev dioksid (E171) i dodatno za Memantine Merz 10 mg filmom obložene tablete žuti željezov oksid (E172), a za Memantine Merz 15 mg i Memantine Merz 20 mg filmom obložene tablete žuti i crveni željezov oksid (E172), sve u ovojnici tablete.
No data on the use of memantine in patients with severe hepatic impairment are available. 
Nisu dostupni podaci o primjeni memantina kod bolesnika s teškim oštećenjem jetrene funkcije.
EU/1/12/799/018 840 film-coated tablets (20 packs of 42) EU/1/12/799/024 840 film-coated tablets (20 packs of 42) 
EU/1/12/799/018 840 filmom obloženih tableta (20 pakiranja po 42) EU/1/12/799/024 840 filmom obloženih tableta (20 pakiranja po 42)
14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 42 film-coated tablets 50 film-coated tablets 56 film-coated tablets 98 film-coated tablets 100 film-coated tablets 112 film-coated tablets 
14 filmom obloženih tableta 28 filmom obloženih tableta 30 filmom obloženih tableta 42 filmom obložene tablete 50 filmom obloženih tableta 56 filmom obloženih tableta 98 filmom obloženih tableta 100 filmom obloženih tableta 112 filmom obloženih tableta
Memantine Merz is used for the treatment of patients with moderate to severe Alzheimer's disease. 
Merz se koristi za liječenje bolesnika s umjerenom do teškom Alzheimerovom bolešću.
The following Adverse Reactions listed in the Table below have been accumulated in clinical studies with Memantine Merz and since its introduction in the market. 
U sljedećoj tablici prikazane su nuspojave prikupljene tijekom kliničkih ispitivanja s Memantine Merzom i nakon stavljanja lijeka u promet.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR 28 TABLETS - TREATMENT INITIATION PACK - 4 WEEK TREATMENT SCHEDULE 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA 28 TABLETA - PAKIRANJE ZA POČETAK
For memantine, no clinical data on exposed pregnancies are available. 
Nema kliničkih podataka o izloženosti memantinu u trudnoći.
When patients were identified with concurrent worsening in all three domains, results showed a statistically significant effect of memantine in preventing worsening, as twice as many placebo-treated patients as memantine-treated patients showed worsening in all three domains (21% vs. 11%, p<0.0001). 
U skupini bolesnika liječenih placebom bilo je dvostruko više pogoršanja u sva tri područja nego u skupini bolesnika liječenih memantinom (21% naspram 11%, p<0,0001).
The dosing pump head has two positions and is easy to turn - anticlockwise (unlocked position) and clockwise (locked position). 
Uporaba pumpice za doziranje za raspršivanje: Vrh pumpice za doziranje ima dva položaja i lako ga je okrenuti - u smjeru suprotnom od kazaljke na satu (otključani položaj) i u smjeru kazaljke na satu (zaključani položaj).
In these situations the treatment should be carefully supervised, and the clinical benefit of Memantine Merz reassessed by your doctor on a regular basis. 
U tim slučajevima liječenje mora biti pažljivo nadzirano, a liječnik treba redovito ponovno procjenjivati kliničku korist od uzimanja Memantine Merz.
Concomitant use of N-methyl-D-aspartate(NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided. 
Treba izbjegavati istodobnu primjenu antagonista N-metil-D-aspartata (NMDA) kao što su amantadin, ketamin ili dekstrometorfan.
In order to reduce the risk of undesirable effects the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows. 
Radi smanjenja rizika od nuspojava, doza održavanja se postiže povećavanjem doze od 5 mg tjedno tijekom prva 3 tjedna na sljedeći način.
In order to reduce the risk of undesirable effects the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows: 
Radi smanjenja rizika od nuspojava, doza održavanja se postiže povećavanjem doze od 5 mg tjedno tijekom prva 3 tjedna na sljedeći način:
Standard clinical procedures to remove active substance material, e.g. gastric lavage, carbo medicinalis (interruption of potential entero-hepatic recirculation), acidification of urine, forced diuresis should be used as appropriate. 
Treba koristiti standardne kliničke postupke za uklanjanje djelatne tvari, npr. ispiranje želuca, primjenu medicinskog ugljena (prekidanje potencijalne enterohepatičke recirkulacije),
Concomitant use of other N-methyl-D-aspartate (NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided. 
Treba izbjegavati istodobnu primjenu drugih antagonista N-metil-D-aspartata (NMDA) kao što su amantadin, ketamin ili dekstrometorfan.
14 film-coated tablets 28 film-coated tablets 42 film-coated tablets 56 film-coated tablets 98 film-coated tablets 
14 filmom obloženih tableta 28 filmom obloženih tableta 42 filmom obložene tablete 56 filmom obloženih tableta 98 filmom obloženih tableta
Memantine Merz contains the active substance memantine hydrochloride. 
Memantine Merz sadrži djelatnu tvar memantinklorid.
H. Abbe Pharma GmbH Tel.: +370 52 711710 
Abbe Pharma GmbH Tel.: +370 52 711710
In volunteers with normal kidney function, total clearance (Cltot) amounts to 170 ml/min/1.73 m² and part of total renal clearance is achieved by tubular secretion. 
Kod dobrovoljaca s normalnom funkcijom bubrega, ukupni klirens (Cltot) iznosi do 170 ml/min/1,73 m², a dio ukupnog bubrežnog klirensa postiže se tubularnom sekrecijom.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR 42, 50 AND 98 TABLETS AS INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA 42, 50 I 98 TABLETA KAO SREDNJE PAKIRANJE / DIO VIŠESTRUKOG PAKIRANJA (BEZ PLAVOG OKVIRA)
Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4- and 6-hydroxy-memantine, and 1-nitroso-3,5-dimethyl-adamantane. 
Glavni metaboliti kod ljudi su N-3,5-dimetil-gludantan, izomerna mješavina 4- i 6-hidroksi-memantina i 1-nitrozo-3,5dimetil-adamantan.
The recommended dose of Memantine Merz for adults and older people is four pump actuations, equivalent to 20 mg once a day. 
Preporučena doza Memantine Merza za odrasle i starije osobe je četiri potiska pumpice, što odgovara 20 mg jednom dnevno.
In single-dose pharmacokinetic (PK) studies in young healthy subjects no relevant active substance-active substance interaction of memantine with glyburide/metformin or donepezil was observed. 
U farmakokinetičkim ispitivanjima (PK) u kojima su primijenjene pojedinačne doze kod mladih zdravih ispitanika nije uočena značajna interakcija djelatna tvar-djelatna tvar memantina s gliburidom/metforminom ili donepezilom.
H. Abbe Pharma GmbH Tel.: +372 6 460980 
Abbe Pharma GmbH Tel.: +372 6 460980
PARTICULARS TO APPEAR ON THE OUTER PACKAGING INNER CARTON FOR BLISTER PACK; frontside 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU UNUTARNJA KUTIJA ZA BLISTER; prednja strana
The usual starting dose is half a tablet once a day (1x 5 mg) for the first week. 
Uobičajena početna doza iznosi pola tablete jedanput na dan (1 x 5 mg) tijekom prvog tjedna.
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg tablets 
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg tablete
In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme: 
Kako bi se smanjio rizik od nuspojava, ta doza se postiže postupno pridržavajući se sljedeće sheme dnevnog liječenja:
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals. 
U tom slučaju, liječnik treba u određenim razmacima nadzirati funkciju bubrega.
In single-dose pharmacokinetic (PK) studies in young healthy subjects no relevant active substanceactive substance interaction of memantine with glyburide/metformin or donepezil was observed. 
U farmakokinetičkim ispitivanjima (PK) u kojima su primijenjene pojedinačne doze kod mladih zdravih ispitanika nije uočena značajna interakcija djelatna tvar-djelatna tvar između memantina i gliburida/metformina ili donepezila.
EXP {MM/YYYY} See embossed stamp. 
Rok valjanosti {MM/GGGG} Vidjeti reljefni otisak.
What is Memantine Merz used for 
Za što se Memantine Merz koristi
In clinical trials in mild to severe dementia, involving 1,784 patients treated with Memantine Merz and 1,595 patients treated with placebo, the overall incidence rate of adverse reactions with Memantine Merz did not differ from those with placebo; the adverse reactions were usually mild to moderate in severity. 
Merzom, a 1595 ih je dobivalo placebo sveukupna stopa incidencije nuspojava u skupini liječenoj Memantine Merzom nije se razlikovala od stope incidencije nuspojava u skupini koja je primala placebo.
The usual starting dose is one pump actuation (1 x 5 mg) once daily for the first week. 
Uobičajena početna doza je jedan potisak pumpice jednom dnevno (1 x 5 mg) tijekom prvog tjedna.
H. Abbe Pharma GmbH Tel.: +371 67 103203 
Abbe Pharma GmbH Tel.: +371 67 103203
The recommended daily dose is 20 mg once a day. 
Preporučena dnevna doza je 20 mg jedanput na dan.
The Memantine Merz treatment initiation pack is only to be used for the beginning of the treatment with Memantine Merz. 
Pakovanje ovaj lijek za početak liječenja se treba koristiti samo na početku liječenja Memantine
Do not store above 30ºC. 
POSEBNE MJERE ČUVANJA Ne čuvati na temperaturi iznad 30ºC.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 42 tablets, 56 tablets, 98 tablets or in multipacks of 840 (20 x 42) tablets. 
Memantine Merz filmom obložene tablete su dostupne u pakiranjima s blisterima od 14 tableta, 28 tableta, 42 tablete, 56 tableta, 98 tableta i višestrukim pakiranjima od 840 (20 pakiranja od 42) tableta.
Memantine Merz should be taken once daily at the same time each day. 
Merz se mora uzimati jednom dnevno, svaki dan u isto vrijeme.
Balance disorder 
Često poremećaj ravnoteže
How to take Memantine Merz 
KAKO UZIMATI MEMANTINE MERZ
No adverse effects of memantine were noted on non-clinical male and female fertility studies. 
Štetni učinci memantina u nekliničkim ispitivanjima plodnosti kod mužjaka i ženki nisu zabilježeni.
Venous thrombosis/thromboembolism 
Manje često venska tromboza/tromboembolija